Resveratrol nanoparticles: A promising therapeutic advancement over native resveratrol

33Citations
Citations of this article
57Readers
Mendeley users who have this article in their library.

Abstract

The importance of fruit-derived resveratrol (RES) in the treatment of various diseases has been discussed in various research publications. Those research findings have indicated the ability of the molecule as therapeutic in the context of in vitro and in vivo conditions. Mostly, the application of RES in in vivo conditions, encapsulation processes have been carried out using various nanoparticles that are made of biocompatible biomaterials, which are easily digested or metabolized, and RES is absorbed effectively. These biomaterials are non-toxic and are safe to be used as components in the biotherapeutics. They are made from naturally available by-products of food materials like zein or corn or components of the physiological system as with lipids. The versatility of the RES nanoparticles in their different materials, working range sizes, specificity in their targeting in various human diseases, and the mechanisms associated with them are discussed in this review.

Cite

CITATION STYLE

APA

Chung, I. M., Subramanian, U., Thirupathi, P., Venkidasamy, B., Samynathan, R., Gangadhar, B. H., … Thiruvengadam, M. (2020, April 1). Resveratrol nanoparticles: A promising therapeutic advancement over native resveratrol. Processes. MDPI AG. https://doi.org/10.3390/PR8040458

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free